A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients

Piersma, D.; Berns, E.M.J.J.; Verhoef-Post, M.; Uitterlinden, A.G.; Braakman, L.J.; Pols, H.A.P.; Themmen, A.P.N.

A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients

DSpace/Manakin Repository

A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients

Piersma, D.; Berns, E.M.J.J.; Verhoef-Post, M.; Uitterlinden, A.G.; Braakman, L.J.; Pols, H.A.P.; Themmen, A.P.N.

(2006) Journal of Clinical Endocrinology and Metabolism, volume 91, issue 4, pp. 1470 - 1476

(Article)

Download/Full Text

Open Access version via Utrecht University Repository

Unknown

ISSN: 0021-972X

Publisher: The Endocrine Society

(Peer reviewed)

See more statistics about this item